The characterization of the immune TME of cancers was an early application of ML/DL methods to pathology specimens; however, computational pathology is now enabling the accurate quantification of TILs and PD‐L1 in tumor and immune cells that goes beyond that attainable by visual quantification. The gene discussed is CD274; the disease is cancer.